정경희 교수 연구실
article|
gold
·인용수 0
·2026
Blood Based Biomarkers for Predicting Treatment Response to Immune Checkpoint Inhibitors After <scp>EGFR</scp> ‐ <scp>TKI</scp> Resistance in Non‐Small Cell Lung Cancer
Min Seok Park, Jun Hyeok Lim, N. Park, EunJi Park, Ayoung Lim, Suji Lee, Yejin Cho, Sehan Kwak, M. H. Lee, Donghyun Seo, L. Kim, Woo Kyung Ryu, Jeong‐Seon Ryu, Eun Young Kim, Soon‐Sun Hong, Kyung Hee Jung
IF 2.3Thoracic Cancer
초록
Plasma-based immune markers measured at the time of TKI resistance may help predict which patients with EGFR-mutant NSCLC will respond to subsequent ICI therapy. Such biomarkers could guide immunotherapy decision-making in this clinically challenging population.
키워드
Lung cancerImmunotherapyBiomarkerEpidermal growth factor receptorImmunohistochemistryImmune systemImmune checkpointTyrosine kinaseCancer